Outlook Therapeutics, Inc. Common Stock vs. Repligen Corp
Outlook Therapeutics, Inc. Common Stock and Repligen Corp are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| OTLK | RGEN | |
|---|---|---|
| Market Cap | $114.23 million | $10.98 billion |
RGEN leads on 1 of 1 size & scale factors.
Risk & Sentiment
| OTLK | RGEN | |
|---|---|---|
| Short Interest | 0.03% | 7.13% |
OTLK leads on 1 of 1 risk & sentiment factors.
Dig deeper: OTLK overview, OTLK financials, RGEN overview, RGEN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.